Evidence map›Paper›PMID 35676258›Full record

ArticleNature communications2022

The structure of EXTL3 helps to explain the different roles of bi-domain exostosins in heparan sulfate synthesis.

L F L Wilson, T Dendooven, S W Hardwick, A Echevarría-Poza, T Tryfona, K B R M Krogh, D Y Chirgadze, B F Luisi, D T Logan, K Mani and 1 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Structural glycobiology - from enzymes to organelles.Biochemical Society transactions · 2025
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. DALI shines a light on remote homologs: One hundred discoveries.Protein science : a publication of the Protein Society · 2023
    Article
  17. Article
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 4 countries.

L F L WilsonDepartment of Biochemistry, University of Cambridge, Cambridge, CB2 1QW, UK.ORCID 0000-0001-6438-3328
T DendoovenDepartment of Biochemistry, University of Cambridge, Cambridge, CB2 1GA, UK.ORCID 0000-0002-9847-0910
S W HardwickDepartment of Biochemistry, University of Cambridge, Cambridge, CB2 1GA, UK.ORCID 0000-0001-9246-1864
A Echevarría-PozaDepartment of Biochemistry, University of Cambridge, Cambridge, CB2 1QW, UK.
T TryfonaDepartment of Biochemistry, University of Cambridge, Cambridge, CB2 1QW, UK.ORCID 0000-0002-1618-3521
K B R M KroghDepartment of Protein Biochemistry and Stability, Novozymes A/S, Krogshøjvej 36, 2880, Bagsværd, Denmark.
D Y ChirgadzeDepartment of Biochemistry, University of Cambridge, Cambridge, CB2 1GA, UK.ORCID 0000-0001-9942-0993
B F LuisiDepartment of Biochemistry, University of Cambridge, Cambridge, CB2 1GA, UK.ORCID 0000-0003-1144-9877
D T LoganBiochemistry and Structural Biology, Centre for Molecular Protein Science, Department of Chemistry, Lund University, SE-221 00, Lund, Sweden.ORCID 0000-0002-0098-8560
K ManiDepartment of Experimental Medical Science, Division of Neuroscience, Glycobiology Group, Lund University, SE-221 00, Lund, Sweden. katrin.mani@med.lu.se.ORCID 0000-0002-1821-0634
P DupreeDepartment of Biochemistry, University of Cambridge, Cambridge, CB2 1QW, UK. pd101@cam.ac.uk.ORCID 0000-0001-9270-6286
University of Cambridge · GBLund University · SEMRC Laboratory of Molecular Biology · GBNovozymes (Denmark) · DK

Funding

Biotechnology and Biological Sciences Research Council BB/L014130/1Wellcome TrustWellcome Trust 200873/Z/16/Z
6 · The paper itself

Abstract

Heparan sulfate is a highly modified O-linked glycan that performs diverse physiological roles in animal tissues. Though quickly modified, it is initially synthesised as a polysaccharide of alternating β-D-glucuronosyl and N-acetyl-α-D-glucosaminyl residues by exostosins. These enzymes generally possess two glycosyltransferase domains (GT47 and GT64)-each thought to add one type of monosaccharide unit to the backbone. Although previous structures of murine exostosin-like 2 (EXTL2) provide insight into the GT64 domain, the rest of the bi-domain architecture is yet to be characterised; hence, how the two domains co-operate is unknown. Here, we report the structure of human exostosin-like 3 (EXTL3) in apo and UDP-bound forms. We explain the ineffectiveness of EXTL3's GT47 domain to transfer β-D-glucuronosyl units, and we observe that, in general, the bi-domain architecture would preclude a processive mechanism of backbone extension. We therefore propose that heparan sulfate backbone polymerisation occurs by a simple dissociative mechanism.

Indexed as

Heparan SulfateN-AcetylglucosaminyltransferasesAnimalsMiceExtl3 protein, mouseHeparan SulfateN-Acetylglucosaminyltransferases

Identifiers

PMID35676258
PMCPMC9178029
OpenAlexW4282933962

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.